MICHELLE SCARGLE: Open Payments
NPI 1093867012 · CLEARWATER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$364,811 in 520 payments from 20 companies in 2025. Trend: 2023 $198,516 · 2024 $259,865 · 2025 $364,811
Speaker / faculty: $193,099Honoraria: $111,094Travel & lodging: $32,750Consulting: $17,024Food & beverage: $10,773Education: $71
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 137 | $121,925 |
| Teva Pharmaceuticals USA, Inc. | 109 | $93,331 |
| E.R. Squibb & Sons, L.L.C. | 94 | $86,972 |
| Neurocrine BioSciences, Inc. | 57 | $32,073 |
| ABBVIE INC. | 42 | $19,633 |
| Alkermes, Inc. | 20 | $9,666 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $291 |
| Otsuka America Pharmaceutical, Inc. | 14 | $213 |
| Corium, LLC | 5 | $139 |
| Vanda Pharmaceuticals Inc. | 4 | $125 |
Products named: Auvelity, AUSTEDO XR, COBENFY, INGREZZA, VRAYLAR, LYBALVI, AUSTEDO, CAPLYTA.
Industry payments across FL — which companies pay providers there.
